Chunyan Yue

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Cell Cycle Arrest

Induced Apoptosis

Top Venues

Nature nanotechnology

Artificial cells, nanomedicine, and biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Chunyan Yue, Wenjing Lu, Shuxin Fan, Zhusheng Huang, Jiaying Yang, Hong Dong, Xiaojun Zhang, Yuxin Shang, Wenjia Lai, Dandan Li, Tiejun Dong, Ahu Yuan, Jinhui Wu, Lifeng Kang, Yiqiao Hu
Nanoparticles for inducing Gaucher disease-like damage in cancer cells. Nature nanotechnology 19 (8) (2024)
Chunyan Yue, Wenjing Lu, Shuxin Fan, Zhusheng Huang, Jiaying Yang, Hong Dong, Xiaojun Zhang, Yuxin Shang, Wenjia Lai, Dandan Li, Tiejun Dong, Ahu Yuan, Jinhui Wu, Lifeng Kang, Yiqiao Hu
Nanoparticles for inducing Gaucher disease-like damage in cancer cells. Nature nanotechnology (2024)
Chunyan Yue, Wenjing Lu, Shuxin Fan, Zhusheng Huang, Jiaying Yang, Hong Dong, Xiaojun Zhang, Yuxin Shang, Wenjia Lai, Dandan Li, Tiejun Dong, Ahu Yuan, Jinhui Wu, Lifeng Kang, Yiqiao Hu
Nanoparticles for inducing Gaucher disease-like damage in cancer cells. Nature nanotechnology 19 (8) (2024)
Yan Ma, Wenjia Lai, Minzhi Zhao, Chunyan Yue, Fanghao Shi, Ren Li, Zhiyuan Hu
Plastin 3 down-regulation augments the sensitivity of MDA-MB-231 cells to paclitaxel via the p38 MAPK signalling pathway. Artificial cells, nanomedicine, and biotechnology 47 (1) (2019)
Chunyan Yue, Manyi Yang, Qinggang Tian, Fongming Mo, Jian Peng, Yan Ma, Yanning Huang, Dongcui Wang, Yuehua Wang, Zhiyuan Hu
IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma. Artificial cells, nanomedicine, and biotechnology 46 (sup2) (2018)